Copi is required for Enterovirus 71 replication

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wang, Jianmin ^a   Wu, Zhiqiang ^a   Jin, Qi ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; COAT PROTEIN COMPLEX I; COAT PROTEIN COMPLEX II; COATOMER PROTEIN; GLUTATHIONE TRANSFERASE; GOLGICIDE A; PROTEIN 2C; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENTEROVIRUS 71; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; VIRUS ENTRY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BREFELDIN A; CARRIER PROTEINS; CELL LINE; COAT PROTEIN COMPLEX I; ENTEROVIRUS A, HUMAN; HUMANS; PROTEIN BINDING; VIRAL NONSTRUCTURAL PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ENTEROVIRUS; HUMAN ECHOVIRUS 11; HUMAN ENTEROVIRUS 71; PICORNAVIRIDAE; POLIOVIRUS;

EID: 84861466113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038035     Document Type: Article

References (60)

1. Liao HT, Hung KL, (2001) Neurologic involvement in an outbreak of enterovirus 71 infection: a hospital-based study. Acta paediatrica taiwanica. 42: 27-32.
2. McMinn P, Stratov I, Nagarajan L, Davis S, (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 32: 236.
3. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, et al. (2009) Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 15: 794-797.
4. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, et al. (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 15: 798-801.
5. Jang S, Pestova T, Hellen C, Witherell G, Wimmer E, (1990) Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme. 44: 292.
6. AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, et al. (1999) Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61: 1-9.
7. McMinn P, Stratov I, Nagarajan L, Davis S, (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 32: 236-242.
8. Craig ME, Vale T, Robertson P, Rawlinson WD, Gould B, (1999) Enterovirus 71 infection in Australian expatriate children following an outbreak in Malaysia. J Paediatr Child Health. 35: 107-108.
9. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, et al. (2001) Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 75: 7732-7738.
10. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis. 52: 12-15.
11. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, et al. (2002) Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 46: 621-627.
12. Chu PY, Lin KH, Hwang KP, Chou LC, Wang CF, et al. (2001) Molecular epidemiology of enterovirus 71 in Taiwan. Arch Virol. 146: 589-600.
13. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, et al. (2009) An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 44: 262-267.
14. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol. 47: 2351.
15. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, et al. (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China. Virol J. 7: 94.
16. Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY, (2007) Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics. 120: e244.
17. Buck KW, (1996) Comparison of the replication of positive-stranded RNA viruses of plants and animals. Adv Virus Res. 47: 159-251.
18. Bienz K, Egger D, Pfister T, Troxler M, (1992) Structural and functional characterization of the poliovirus replication complex. J Virol. 66: 2740.
19. Bienz K, Egger D, Pfister T, (1994) Characteristics of the poliovirus replication complex. Arch Virol (Suppl. 9): 147.
20. Salonen A, Ahola T, Kaariainen L, (2005) Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol pp. 139-173.
21. Lee MCS, Miller EA, Goldberg J, Orci L, Schekman R, (2004) Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol. 20: 87-123.
22. Beller M, Sztalryd C, Southall N, Bell M, J ckle H, et al. (2008) COPI complex is a regulator of lipid homeostasis. PLoS biology. 6: e292.
23. Egger D, Bienz K, (2005) Intracellular location and translocation of silent and active poliovirus replication complexes. J Gen Virol. 86: 707.
24. Rust RC, Landmann L, Gosert R, Tang BL, Hong W, et al. (2001) Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol. 75: 9808.
25. Schlegel A, Giddings TH Jr, Ladinsky MS, Kirkegaard K, (1996) Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol. 70: 6576.
26. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell host microbe. 5: 298-307.
27. Gazina EV, Mackenzie JM, Gorrell RJ, Anderson DA, (2002) Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae. J Virol. 76: 11113.
28. Irurzun A, Perez L, Carrasco L, (1992) Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology. 191: 166-175.
29. Maynell LA, Kirkegaard K, Klymkowsky MW, (1992) Inhibition of poliovirus RNA synthesis by brefeldin A. J Virol. 66: 1985.
30. van der Linden L, van der Schaar HM, Lanke KHW, Neyts J, van Kuppeveld FJM, (2010) Differential effects of the putative GBF1 inhibitors golgicide A and AG1478 on enterovirus replication. J Virol. 84: 7535.
31. O'Donnell VK, Pacheco JM, Henry TM, Mason PW, (2001) Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology. 287: 151-162.
32. Cherry S, Kunte A, Wang H, Coyne C, Rawson RB, et al. (2006) COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLoS pathog. 2: e102.
33. Wu Z, Yang F, Zhao R, Zhao L, Guo D, et al. (2009) Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. J Virol Methods. 159: 233-238.
34. Cherry S, Doukas T, Armknecht S, Whelan S, Wang H, et al. (2005) Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 19: 445.
35. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science. 319: 921.
36. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell host microbe. 4: 495-504.
37. Lippincott-Schwartz J, Donaldson JG, Schweizer A, Berger EG, Hauri HP, et al. (1990) Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell. 60: 821-836.
38. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD, (1989) Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 56: 801-813.
39. Stamnes MA, Rothman JE, (1993) The binding of AP-1 clathrin adaptor particles to Golgi membranes requires ADP-ribosylation factor, a small GTP-binding protein. Cell. 73: 999-1005.
40. Orcl L, Tagaya M, Amherdt M, Perrelet A, Donaldson JG, et al. (1991) Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell. 64: 1183-1195.
41. Ward TH, Polishchuk RS, Caplan S, Hirschberg K, Lippincott-Schwartz J, (2001) Maintenance of Golgi structure and function depends on the integrity of ER export. J Cell Biol. 155: 557.
42. Bednarek SY, Ravazzola M, Hosobuchi M, Amherdt M, Perrelet A, et al. (1995) COPI-and COPII-coated vesicles bud directly from the endoplasmic reticulum in yeast. Cell. 83: 1183-1196.
43. De Lisle R, Bansal R, (1996) Brefeldin A inhibits the constitutive-like secretion of a sulfated protein in pancreatic acinar cells. EUR J Cell Biol. 71: 62.
44. Fernandez CJ, Haugwitz M, Eaton B, Moore HPH, (1997) Distinct molecular events during secretory granule biogenesis revealed by sensitivities to brefeldin A. Mol Biol Cell. 8: 2171.
45. Doedens J, Maynell L, Klymkowsky M, Kirkegaard K, (1994) Secretory pathway function, but not cytoskeletal integrity, is required in poliovirus infection. Arch Virl (Suppl. 9): 159.
46. Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E, (1994) Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology. 202: 129-145.
47. Echeverri AC, Dasgupta A, (1995) Amino terminal regions of poliovirus 2C protein mediate membrane binding. Virology. 208: 540-553.
48. Crotty S, Saleh MC, Gitlin L, Beske O, Andino R, (2004) The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol. 78: 3378-3386.
49. Barco A, Carrasco L, (1998) Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J Virol. 72: 3560.
50. Deitz SB, Dodd DA, Cooper S, Parham P, Kirkegaard K, (2000) MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci. 97: 13790.
51. Doedens JR, Kirkegaard K, (1995) Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14: 894.
52. Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E, (2008) A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS pathog. 4: e1000216.
53. Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, et al. (2006) A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell. 11: 191-201.
54. Lanke KH, van der Schaar HM, Belov GA, Feng Q, Duijsings D, et al. (2009) GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol. 83: 11940-11949.
55. Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E, (2008) A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog. 4: e1000216.
56. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, et al. (2005) Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol. 79: 4382.
57. Moffat K, Knox C, Howell G, Clark SJ, Yang H, et al. (2007) Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J Virol. 81: 1129.
58. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
59. Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, et al. (2006) A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J Biomol Screen. 11: 351-358.
60. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27: 493.